1-2 of 2
Ewa Chmielowska, MD
Close
Sort by
Journal Articles

Single-Agent Ibrutinib Demonstrates Safety and Durability of Response at 2 Years Follow-up in Patients with Relapsed or Refractory Mantle Cell Lymphoma: Updated Results of an International, Multicenter, Open-Label Phase 2 Study

Michael Wang, MD, Simon Rule, MD, Peter Martin, MD, Andre Goy, MD, Rebecca Auer, MD PhD, Brad S. Kahl, MD, Wojciech Jurczak, Ranjana Advani, MD, Jorge E. Romaguera, MD, Michael E. Williams, MD, Jacqueline C. Barrientos, MD, Ewa Chmielowska, MD, John Radford, Stephan Stilgenbauer, MD, Martin Dreyling, Wieslaw Wiktor Jedrzejczak, MD, Peter W Johnson, MD, Stephen E. Spurgeon, MD, Liang Zhang, MD PhD, Linda Baher, Mei Cheng, PhD, Darrin M. Beaupre, MD, Kristie A. Blum, MD
Journal: Blood
Blood (2014) 124 (21): 4453.
https://doi.org/10.1182/blood.V124.21.4453.4453
Published: 2014
Journal Articles

Hodgkin Lymphoma in Older Patients- a Retrospective Analysis of the Polish Lyphoma Reasearch Group

Tomasz Wrobel, MDPhD, Olga Dobrzynska, Ewa Chmielowska, MD, Elzbieta Nowara, Agnieszka Badora-Rybicka, Anna Szulgo, Natalia Sorbotten, Wojciech Jurczak, Giza Agnieszka, Krzysztof Adamowicz, Agata Bartoszko, Krzysztof Lesniewski-Kmak, Wanda Knopinska-Posluszny, Waldemar Kulikowski, Renata Kroll, Andrzej Balcerzak, Wojciech Spychalowicz, Ewa Kalinka-Warzocha, Beata Kumiega, Joanna E Drozd-Sokolowska, Edyta Subocz, MD PhD, Agata Salek, Jadwiga Holojda, MD, Joanna Pogrzeba, Jaroslaw Dybko, MD PhD, Rafal Poreba, Jan Maciej Zaucha, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1737.
https://doi.org/10.1182/blood.V124.21.1737.1737
Published: 2014